The index assay was selected for its ability to measure both IgM and IgG antibodies that target Borrelia’s pleomorphic forms [37], including the round body or persistent forms, as well as a range of common opportunistic pathogens and co-infections simultaneously. The gene discussed is CD40LG; the disease is coinfection.